Welcome to the IPVC 2021 Conference Program Scheduling.
The meeting will officially run on Toronto Local Time (GMT-5)

To convert the meeting times to your local timeclick here

Please note that the viewing of the sessions cannot be accessed from this Conference calendar.
All sessions will be available via the Main Lobby on the Virtual Platform.

   

 - Live Sessions   - Pre-Recorded   - Pre-Recorded with Live Q&A

Displaying One Session

Session Type
Industry Sponsored Session
Date
Wed, Nov 17, 2021
Session Time
12:45 PM - 02:15 PM
Chair(s)
Session Description
Screening Smarter in the Post-Pandemic Era: The Clinical Utility of Extended Genotyping and Self-Collection - Supported by BD

Session Description:

Screening Smarter in the Post-Pandemic Era: The Clinical Utility of Extended Genotyping and Self-Collection- Supported by BD Session Description: Session Description: The title of the BD Symposium will be, “Screening Smarter in the Post-Pandemic Era: The Clinical Utility of Extended Genotyping and Self-Collection”. The moderator, Marie-Hélène Mayrand, MD, PhD, FRCSC of the Université de Montréal will introduce the symposium and the three symposium speakers. Jesper Bonde, Ph.D., head of the Molecular Pathology Laboratory, Hvidovre Hospital, Denmark will present scientific evidence from a clinical validation of the high-throughput BD COR™ System and discuss the Danish experience with Primary HPV screening implementation. Karena Volesky, MS of McGill University, will present evidence from the Canadian Cervical Cancer Screening Trial (CCCaST), including clinical performance of the BD Onclarity extended genotyping assay for the management of women positive for HPV. Jack Cuzick, PhD, FRS, FMedSci, FRCP(hon) of the Wolfson Institute of Preventive Medicine and Head, Centre for Cancer Prevention Centre for Cancer Prevention, Queen Mary University, London, will provide evidence regarding self-collection for Primary HPV screening, utility of extended genotyping and comment on the future of cervical cancer screening. Dr. Mayrand will give her perspective summation of the three presentations before fielding questions from the audience for the panel.

Session Icon
Pre-Recorded with Live Q&A

Screening Smarter in the Post-Pandemic Era: The Clinical Utility of Extended Genotyping and Self-Collection (ID 719)

Lecture Time
12:45 PM - 12:45 PM

Sponsored by BD (ID 720)

Lecture Time
12:45 PM - 12:45 PM

Introduction (ID 721)

Presenter
Lecture Time
12:45 PM - 12:50 PM

Clinical Validation of the high-throughput BD COR™ System – The Danish Experience with Primary Screening Implementation (ID 722)

Presenter
Lecture Time
12:50 PM - 01:05 PM

Clinical performance of the BD Onclarity extended genotyping assay for the management of women positive for human papillomavirus – The Canadian Cervical Cancer Screening Trial (CCCaST) (ID 723)

Presenter
Lecture Time
01:05 PM - 01:20 PM

Self-Collection, Extended Genotyping and the Future of Cervical Cancer Screening (ID 724)

Presenter
Lecture Time
01:20 PM - 01:45 PM

Chairperson’s closing remarks (ID 725)

Presenter
Lecture Time
01:45 PM - 01:55 PM

Live Q&A (ID 1192)

Presenter
Lecture Time
01:55 PM - 02:15 PM